1. Home
  2. CHCT vs VSTM Comparison

CHCT vs VSTM Comparison

Compare CHCT & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Community Healthcare Trust Incorporated

CHCT

Community Healthcare Trust Incorporated

HOLD

Current Price

$17.83

Market Cap

489.7M

Sector

Real Estate

ML Signal

HOLD

Logo Verastem Inc.

VSTM

Verastem Inc.

HOLD

Current Price

$5.69

Market Cap

470.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHCT
VSTM
Founded
2014
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
489.7M
470.7M
IPO Year
2015
2011

Fundamental Metrics

Financial Performance
Metric
CHCT
VSTM
Price
$17.83
$5.69
Analyst Decision
Buy
Strong Buy
Analyst Count
3
7
Target Price
$18.00
$16.50
AVG Volume (30 Days)
186.8K
1.9M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
11.07%
N/A
EPS Growth
134.78
17.49
EPS
0.07
N/A
Revenue
$121,195,000.00
$30,914,000.00
Revenue This Year
$9.06
$282.64
Revenue Next Year
$8.61
$72.25
P/E Ratio
$252.00
N/A
Revenue Growth
4.67
209.14
52 Week Low
$13.23
$4.01
52 Week High
$18.22
$11.25

Technical Indicators

Market Signals
Indicator
CHCT
VSTM
Relative Strength Index (RSI) 60.33 48.11
Support Level $16.38 $5.38
Resistance Level $18.22 $6.79
Average True Range (ATR) 0.50 0.36
MACD 0.01 -0.01
Stochastic Oscillator 78.49 37.08

Price Performance

Historical Comparison
CHCT
VSTM

About CHCT Community Healthcare Trust Incorporated

Community Healthcare Trust Inc is an integrated healthcare real estate company in the United States. The company owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems, or other healthcare service providers in non-urban markets. The company derives the majority of its revenues from its real estate property and mortgage notes portfolio. The company's rental and mortgage interest income is recognized based on contractual arrangements with its tenants and borrowers.

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Share on Social Networks: